{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:22:09Z","timestamp":1790821329781,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91759-6","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:58:53Z","timestamp":1743123533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The preclinical study of biocompatibility of tyrosine polycarbonate bioresorbable scaffold in small caliber porcine peripheral arteries"],"prefix":"10.1038","volume":"15","author":[{"given":"Mateusz","family":"Kachel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H. C.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard B.","family":"Conditt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge D.","family":"Rousselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz L.","family":"Kaluza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"9901","key":"91759_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes, F. G. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382, 1329\u20131340. https:\/\/doi.org\/10.1016\/S0140-6736(13)61249-0 (2013).","journal-title":"Lancet"},{"issue":"3","key":"91759_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","volume":"60","author":"MR Nehler","year":"2014","unstructured":"Nehler, M. R. et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J. Vasc. Surg. 60, 686\u2013695e2. https:\/\/doi.org\/10.1016\/j.jvs.2014.03.290 (2014).","journal-title":"J. Vasc. Surg."},{"key":"91759_CR3","doi-asserted-by":"publisher","unstructured":"Conte, M. S. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J. Vasc. Surg. 69(6S):3S\u2013125S.e40. https:\/\/doi.org\/10.1016\/j.jvs.2019.02.016 (2019).","DOI":"10.1016\/j.jvs.2019.02.016"},{"key":"91759_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijsu.2017.06.075","volume":"44","author":"X Liu","year":"2017","unstructured":"Liu, X., Zheng, G. & Wen, S. Drug-eluting stents versus control therapy in the infrapopliteal disease: A meta-analysis of eight randomized controlled trials and two cohort studies. Int. J. Surg. 44, 166\u2013175. https:\/\/doi.org\/10.1016\/j.ijsu.2017.06.075 (2017).","journal-title":"Int. J. Surg."},{"issue":"2","key":"91759_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","volume":"38","author":"RL Varcoe","year":"2019","unstructured":"Varcoe, R. L., Paravastu, S. C., Thomas, S. D. & Bennett, M. H. The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials. Int. Angiol. 38, 121\u2013135. https:\/\/doi.org\/10.23736\/S0392-9590.19.04049-5 (2019).","journal-title":"Int. Angiol."},{"issue":"7","key":"91759_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","volume":"60","author":"A Rastan","year":"2012","unstructured":"Rastan, A. et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J. Am. Coll. Cardiol. 60, 587\u2013591. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.035 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"91759_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0735-1097(99)00486-6","volume":"35","author":"PH Grewe","year":"2000","unstructured":"Grewe, P. H., Deneke, T., Machraoui, A., Barmeyer, J. & M\u00fcller, K. M. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J. Am. Coll. Cardiol. 35, 157\u2013163. https:\/\/doi.org\/10.1016\/s0735-1097(99)00486-6 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"91759_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner, M. et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48, 193\u2013202. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.042 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"91759_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1583\/08-2530.1","volume":"16","author":"D Karnabatidis","year":"2009","unstructured":"Karnabatidis, D. et al. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J. Endovasc. Ther. 16, 15\u201322. https:\/\/doi.org\/10.1583\/08-2530.1 (2009).","journal-title":"J. Endovasc Ther."},{"key":"91759_CR10","volume-title":"Rutherford\u2019s Vascular Surgery and Endovascular Therapy","author":"K Maeda","year":"2019","unstructured":"Maeda, K. & Ohki, T. Endovascular therapeutic technique. In Rutherford\u2019s Vascular Surgery and Endovascular Therapy 9th edn (eds Sidawy, A. N. & Perler, B. A.) 762\u2013784 (Elsevier, Philadelphia,\u00a02019).","edition":"9"},{"key":"91759_CR11","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska, J. J. et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl. J. Med. 376, 2319\u20132328. https:\/\/doi.org\/10.1056\/NEJMoa1614954 (2017).","journal-title":"N Engl. J. Med."},{"key":"91759_CR12","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","volume":"388","author":"PW Serruys","year":"2016","unstructured":"Serruys, P. W. et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388, 2479\u20132491. https:\/\/doi.org\/10.1016\/S0140-6736(16)32050-5 (2016).","journal-title":"Lancet"},{"key":"91759_CR13","doi-asserted-by":"crossref","unstructured":"Kaluza, G. L. & Granada, J. F. The bioresorbable vascular scaffold tale epilogue: overpromised, underdelivered, prematurely degraded. JACC Cardiovasc. Interv. 12, 980\u2013982 (2019).","DOI":"10.1016\/j.jcin.2019.03.032"},{"key":"91759_CR14","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.4244\/EIJ-D-23-00504","volume":"20","author":"M Lutz","year":"2024","unstructured":"Lutz, M. et al. Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial. EuroIntervention 20, e453\u2013e456. https:\/\/doi.org\/10.4244\/EIJ-D-23-00504 (2024).","journal-title":"EuroIntervention"},{"key":"91759_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2023.04.029","volume":"383","author":"G Pompei","year":"2023","unstructured":"Pompei, G. et al. Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: insights from the SHERPA-MAGIC study. Int. J. Cardiol. 383, 1\u20137 (2023).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"91759_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ccd.29327","volume":"97","author":"RL Varcoe","year":"2021","unstructured":"Varcoe, R. L., Menting, T. P., Thomas, S. D. & Lennox, A. F. Long-term results of a prospective, single-arm evaluation of everolimus-eluting bioresorbable vascular scaffolds in infrapopliteal arteries. Catheter Cardiovasc. Interv. 97, 142\u2013149. https:\/\/doi.org\/10.1002\/ccd.29327 (2021).","journal-title":"Catheter Cardiovasc. Interv"},{"key":"91759_CR17","unstructured":"Rand, T. MOTIV bioresorbable BTK scaffold pilot study. Initial 24 months results. Presented at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress; September 9, 2023; Copenhagen, Denmark."},{"key":"91759_CR18","doi-asserted-by":"publisher","unstructured":"Varcoe, R. L. et al. Drug-Eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease. N. Engl. J. Med. 390, 9\u201319. https:\/\/doi.org\/10.1056\/NEJMoa2305637 (2023).","DOI":"10.1056\/NEJMoa2305637"},{"key":"91759_CR19","unstructured":"Brodmann, M. RESOLV FIH 6-month results by Rutherford classification. Presented at Vascular InterVentional Advances (VIVA) conference; October 31, 2023; Las Vegas, Nevada, USA."},{"key":"91759_CR20","doi-asserted-by":"publisher","unstructured":"Auras, R., Lim, L. T., Selke, S. & Tsuji, H. Poly(lactic acid): synthesis, structures, properties, processing, and applications. 1\u20131. https:\/\/doi.org\/10.1002\/9780470649848 (Wiley, 2010).","DOI":"10.1002\/9780470649848"},{"issue":"2","key":"91759_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCINTERVENTIONS.108.789974","volume":"1","author":"RS Schwartz","year":"2008","unstructured":"Schwartz, R. S. et al. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ. Cardiovasc. Interv. 1, 143\u2013153. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.108.789974 (2008).","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"6","key":"91759_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jvir.2021.02.014","volume":"32","author":"A Sakamoto","year":"2021","unstructured":"Sakamoto, A. et al. Vascular response of a polymer-free paclitaxel-coated stent (Zilver PTX) versus a polymer-coated paclitaxel-eluting stent (Eluvia) in healthy swine femoropopliteal arteries. J. Vasc Interv Radiol. 32 (6), 792\u2013801e5. https:\/\/doi.org\/10.1016\/j.jvir.2021.02.014 (2021).","journal-title":"J. Vasc Interv Radiol."},{"issue":"5","key":"91759_CR23","doi-asserted-by":"publisher","first-page":"e004450","DOI":"10.1161\/CIRCINTERVENTIONS.116.004450","volume":"10","author":"P Gasior","year":"2017","unstructured":"Gasior, P. et al. Impact of fluoropolymer-based paclitaxel delivery on neointimal proliferation and vascular healing: A comparative peripheral drug-eluting stent study in the familial hypercholesterolemic swine model of femoral restenosis. Circ. Cardiovasc. Interv. 10 (5), e004450. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004450 (2017).","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"2","key":"91759_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.107.730010","volume":"120","author":"GJ Wilson","year":"2009","unstructured":"Wilson, G. J. et al. Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries. Circulation 120, 141\u2013142. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.730010 (2009).","journal-title":"Circulation"},{"key":"91759_CR25","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.ijcha.2021.100792","volume":"34","author":"T Ijichi","year":"2021","unstructured":"Ijichi, T. et al. Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model. Int. J. Cardiol. Heart Vasc. 34, 100792. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100792 (2021).","journal-title":"Int. J. Cardiol. Heart Vasc"},{"key":"91759_CR26","doi-asserted-by":"publisher","unstructured":"Otsuka, F. et al. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model. Circ. Cardiovasc. Interv. 7, 330\u2013342. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.000990 (2014).","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990"},{"issue":"10","key":"91759_CR27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.4244\/EIJY16M05_01","volume":"12","author":"E Tenekecioglu","year":"2016","unstructured":"Tenekecioglu, E. et al. Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment. EuroIntervention 12, 1296. https:\/\/doi.org\/10.4244\/EIJY16M05_01 (2016).","journal-title":"EuroIntervention"},{"issue":"12","key":"91759_CR28","doi-asserted-by":"publisher","first-page":"e989","DOI":"10.4244\/EIJ-D-19-01128","volume":"16","author":"A Kumar","year":"2020","unstructured":"Kumar, A. et al. Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III imaging substudy. EuroIntervention 16 (12), e989\u2013e996. https:\/\/doi.org\/10.4244\/EIJ-D-19-01128 (2020).","journal-title":"EuroIntervention"},{"issue":"7","key":"91759_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jcin.2013.04.008","volume":"6","author":"BD Gogas","year":"2013","unstructured":"Gogas, B. D. et al. Biomechanical assessment of fully bioresorbable devices. JACC Cardiovasc. Interv. 6, 760\u2013761. https:\/\/doi.org\/10.1016\/j.jcin.2013.04.008 (2013).","journal-title":"JACC Cardiovasc. Interv"},{"issue":"25","key":"91759_CR30","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2007.02.059","volume":"49","author":"YS Chatzizisis","year":"2007","unstructured":"Chatzizisis, Y. S. et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 49, 2379\u20132393. https:\/\/doi.org\/10.1016\/j.jacc.2007.02.059 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"91759_CR31","doi-asserted-by":"publisher","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","volume":"8","author":"T Koppara","year":"2015","unstructured":"Koppara, T. et al. Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents. Circ. Cardiovasc. Interv. 8, e002427. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.115.002427 (2015).","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"8","key":"91759_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1253\/circj.CJ-17-0152","volume":"81","author":"J Kang","year":"2017","unstructured":"Kang, J. et al. Bioresorbable vascular scaffolds - Are we facing a time of crisis or one of breakthrough? Circ. J. 81 (8), 1065\u20131074. https:\/\/doi.org\/10.1253\/circj.CJ-17-0152 (2017).","journal-title":"Circ. J."},{"issue":"1","key":"91759_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/CIRCINTERVENTIONS.113.000738","volume":"7","author":"E Durand","year":"2014","unstructured":"Durand, E. et al. Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study. Circ. Cardiovasc. Interv. 7 (1), 70\u201379. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.000738 (2014).","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"10","key":"91759_CR34","doi-asserted-by":"publisher","first-page":"e004253","DOI":"10.1161\/CIRCINTERVENTIONS.116.004253","volume":"9","author":"Y Cheng","year":"2016","unstructured":"Cheng, Y. et al. Comparative characterization of biomechanical behavior and healing profile of a novel ultra-high-molecular-weight amorphous poly-L-lactic acid sirolimus-eluting bioresorbable coronary scaffold. Circ. Cardiovasc. Interv. 9, e004253. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004253 (2016).","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"1","key":"91759_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCINTERVENTIONS.111.964270","volume":"5","author":"E Strandberg","year":"2012","unstructured":"Strandberg, E., Zeltinger, J., Schulz, D. G. & Kaluza, G. L. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries. Circ. Cardiovasc. Interv. 5, 39\u201346. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.111.964270 (2012).","journal-title":"Circ. Cardiovasc. Interv"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91759-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91759-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91759-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:58:59Z","timestamp":1743123539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91759-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91759"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91759-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been funded by the scientific grant from REVA Medical LLC. Danielle Gram BS, BA and Jeffrey Anderson BS are employees of REVA Medical LLC. No other authors have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10624"}}